Neuromuscular Disease News and Research

RSS
Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Safeway raises funds to support neuromuscular disease medical research and therapies

Safeway raises funds to support neuromuscular disease medical research and therapies

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Muscular Dystrophy Canada to host the 44th Jerry Lewis Labour Day Telethon

Muscular Dystrophy Canada to host the 44th Jerry Lewis Labour Day Telethon

Phase 1 single dose clinical trial of Acceleron Pharma's ACE-031 increases lean body mass

Phase 1 single dose clinical trial of Acceleron Pharma's ACE-031 increases lean body mass

Neuromuscular disorders common among Canadians

Neuromuscular disorders common among Canadians

New approach to remove toxic agent that causes myotonic dystrophy

New approach to remove toxic agent that causes myotonic dystrophy

Electrodiagnostic and neuromuscular medicine featured at AANEM annual meeting

Electrodiagnostic and neuromuscular medicine featured at AANEM annual meeting

Nervous system may be culprit in Pompe disease

Nervous system may be culprit in Pompe disease

Exercise therapy benefits ICU patients

Exercise therapy benefits ICU patients

Carrier screening for spinal muscular atrophy should be offered to all couples

Carrier screening for spinal muscular atrophy should be offered to all couples

Scientists discover new compounds to target muscular dystrophy

Scientists discover new compounds to target muscular dystrophy

Statin-induced muscle disorders are focus of $2.5 million in grants from NIH

Statin-induced muscle disorders are focus of $2.5 million in grants from NIH

New hope for treating common form of inherited neuromuscular disease

New hope for treating common form of inherited neuromuscular disease

Tongue-operated assistive technology lets persons with disabilities operate powered wheelchairs

Tongue-operated assistive technology lets persons with disabilities operate powered wheelchairs

Risk factors for sudden death for adult muscular dystrophy identified

Risk factors for sudden death for adult muscular dystrophy identified

New insight into the genetics of Lou Gehrig's disease

New insight into the genetics of Lou Gehrig's disease

New potential approach to treat spinal muscular atrophy

New potential approach to treat spinal muscular atrophy

Two-way cell talk provides clues about neuromuscular disease

Two-way cell talk provides clues about neuromuscular disease

Potential method for repairing misspelling in DNA code that causes spinal muscular atrophy

Potential method for repairing misspelling in DNA code that causes spinal muscular atrophy